NCT03962556 is a clinical trial of bimanual palpation in Myofascial Pain, sponsored by Necmettin Erbakan University.

Who is sponsoring NCT03962556?

NCT03962556 is sponsored by Necmettin Erbakan University.

What drugs are being tested in NCT03962556?

Interventions in NCT03962556: bimanual palpation.

What condition does NCT03962556 study?

NCT03962556 studies Myofascial Pain.

Is NCT03962556 still recruiting?

NCT03962556 is currently status unknown. Last updated 20 August 2019.

Last reviewed 2019-08-20 · How we verify

NCT03962556

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Distribution of Trigger Points in Patient Who Have Myofascial Pain Disorder

Status unknown Last updated 20 August 2019

What this trial tests

trial testing bimanual palpation in Myofascial Pain in 200 participants. Status unknown.

Timeline

15 December 2018

Primary endpoint
15 January 2020

15 April 2020

Quick facts

Lead sponsor	Necmettin Erbakan University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	200
Start date	15 December 2018
Primary completion	15 January 2020
Estimated completion	15 April 2020
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

bimanual palpation

Conditions studied

Myofascial Pain — all drugs for Myofascial Pain →

Sponsor

Necmettin Erbakan University

Who can join

Adults 18 to 65, any sex, with Myofascial Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Myofascial pain alone covers 45.3% of the diagnosis of TMJ. It is defined as palpation sensitivity and regional muscle pain. Clinically muscle pain connects to myofascial trigger points.These trigger points are hypersensitive points located in a tense band of the skeletal muscle, which can be described, causing provoked or spontaneous pain. They are divided into two as active and latent. Those who cause spontaneous pain are active, and those who provoke pain are considered latent.Spasm in the chewing muscles with myofascial pain reduces the patient's pain threshold and quality of life. Therefore, patients with spasm and TMJ pain in the masticatory muscles should be examined for head and neck muscles, the presence of myofascial trigger points should be determined and the head and neck muscles should be included in physical therapy. The aim of this study was to determine the presence of myofascial trigger points in patients presenting with pain in the masticatory muscles and TMJ region, and to determine the relationship between the presence of trigger point and the degree of pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Myofascial Pain

Currently open trials in the same condition.

NCT07278570 — Magnetic Resonance Elastography to Monitor Response to Manual Therapy in Myofascial Pain · NA · recruiting
NCT06036524 — Multi-modal Imaging of Myofascial Pain · NA · active not recruiting
NCT05793086 — Evaluation of a Novel Class of Objective Myofascial Pain Assessments · active not recruiting

Other Necmettin Erbakan University trials

Trials by the same sponsor.

NCT07128407 — PMT-Based Radiation Safety Training for Nurses: Randomized Controlled Trial. · NA · active not recruiting
NCT07504770 — Surgical Glove Compression to Prevent Paclitaxel Neuropathy · NA · not yet recruiting
NCT07242807 — Minimally Invasive Prostate Interventions Registry (MIST Study) · not yet recruiting
NCT07442331 — The Effect of Game-Based Learning on Identifying Cognitive Distortions and Interpersonal Communication Competence in Nur · NA · completed
NCT07396038 — INTRAOPERATIVE BLADDER INJURY ASSESSMENT IN TURBT USING BICEP · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03962556 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Necmettin Erbakan University
Last refreshed: 20 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03962556.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing